Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martti Nurmi

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Urology|January 29, 2014
Cancer-associated changes in the expression of TMPRSS2-ERG, PCA3, and SPINK1 in histologically benign tissue from cancerous vs noncancerous prostatectomy specimensRiina-Minna Väänänen, Hans Lilja, Leni Kauko, et al.
BJU International|May 4, 2012
Does patient age affect survival after radical cystectomy?David Horovitz, Polat Turker, Peter J Bostrom, et al.
International Journal of Cancer|February 19, 2016
Increased expression of fibroblast growth factor 13 in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomyLan Yu, Mervi Toriseva, Miikka Tuomala, et al.
Cancer Research|July 17, 2004
Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological gradeHongzhen Li, Tommi J Ahonen, Kalle Alanen, et al.
Endocrinology|April 7, 2007
Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathwayAyush Dagvadorj, Sean Collins, Jean-Baptiste Jomain, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 5, 2016
Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical CystectomyPeter J Boström, Tuomas Mirtti, Bas van Rhijn, et al.
Cancers|January 21, 2022
Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer ProgressionLan Yu, Mervi Toriseva, Syeda Afshan, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Urology|January 29, 2014
Cancer-associated changes in the expression of TMPRSS2-ERG, PCA3, and SPINK1 in histologically benign tissue from cancerous vs noncancerous prostatectomy specimensRiina-Minna Väänänen, Hans Lilja, Leni Kauko, et al.
BJU International|May 4, 2012
Does patient age affect survival after radical cystectomy?David Horovitz, Polat Turker, Peter J Bostrom, et al.
International Journal of Cancer|February 19, 2016
Increased expression of fibroblast growth factor 13 in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomyLan Yu, Mervi Toriseva, Miikka Tuomala, et al.
Cancer Research|July 17, 2004
Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological gradeHongzhen Li, Tommi J Ahonen, Kalle Alanen, et al.
Endocrinology|April 7, 2007
Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathwayAyush Dagvadorj, Sean Collins, Jean-Baptiste Jomain, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 5, 2016
Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical CystectomyPeter J Boström, Tuomas Mirtti, Bas van Rhijn, et al.
Cancers|January 21, 2022
Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer ProgressionLan Yu, Mervi Toriseva, Syeda Afshan, et al.
Pageof 3